Status:
COMPLETED
Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
COPD
COPD Exacerbation
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Investigators propose to develop methods to improve early identification of acute exacerbations of COPD (AECOPD) among HIV-infected individuals. Investigators hypothesize that earlier identification o...
Eligibility Criteria
Inclusion
- HIV infected
- Has an established longitudinal care provider in Baltimore, MD
- Confirmed COPD defined as post-bronchodilator FEV1/FVC\<0.70
- Stable residence for duration of 6 month intervention
Exclusion
- Age \< 18 years
- Unable/unwilling to provide informed consent
- Failure to present to randomization visit
Key Trial Info
Start Date :
September 26 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 9 2022
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT01892566
Start Date
September 26 2013
End Date
May 9 2022
Last Update
July 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins ALIVE Clinic
Baltimore, Maryland, United States, 21287